Bayer

News

Bayer bags first world approval for hot flush therapy

Bayer has its first regulatory approval for non-hormonal menopause treatment elinzanetant – in the UK – as it chases down a rival drug from Astellas.

News

After FDA says no, Bayer bags EU nod for twice-yearly Eylea

Bayer has been given a leg up in the competitive market for VEGF therapies used to treat eye diseases with a new EU approval for Eylea 8mg.

R&D

Interview at BIO 2025 with Juergen Eckhardt

Looking to early-stage companies for innovation, with Juerge...

In an interview at BIO 2025, Bayer's Juergen Eckhardt discusses the importance of external innovation and why his company is prioritising early stage.

News

Bayer trial combines two top drugs for kidney disease

Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.

News

Bayer CEO confident firm can cope with Xarelto hit

Bayer's CEO says new product launches will offset the decline in sales of anticoagulant Xarelto over the course of 2025.

News

Bayer CEO warns of tough 2025 as turnaround plan beds in

Things will get tougher before they get better at Bayer, according to CEO Bill Anderson, as the group reports its 2024 financial results.

Bayer bags first world approval for hot flush therapy

After FDA says no, Bayer bags EU nod for twice-yearly Eylea

Looking to early-stage companies for innovation, with Juerge...

Bayer trial combines two top drugs for kidney disease

Bayer CEO confident firm can cope with Xarelto hit

Bayer CEO warns of tough 2025 as turnaround plan beds in

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Bayer

Editor's Picks